One trial opened exclusively at the M Health Fairview University of Minnesota Medical Center for patients with resistant or relapsing AML. It uses molecules to activate the patient’s own NK cells to attack AML tumors.

Dr. Vinogradov focuses on psychotic disorders where individuals experience abnormal thinking and perceptions.

Remembering Longtime Faculty Member & Regional Duluth Campus Dean Emeritus, Dr. Gary L. Davis.